JUPITER NEUROSCIENCES, INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statement of Changes in Stockholders’ Deficit
** CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT**)
FOR THE MONTHS ENDED MARCH 31, 2025 AND 2024
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | (Deficit) | |
| December 31, 2024 | 33,103,860 | $3,310 | $30,190,827 | $(26,022,129) | $4,172,008 |
| Stock-based compensation | - | - | 421,454 | - | 421,454 |
| Net loss | - | - | - | (1,528,867) | (1,528,867) |
| March 31, 2025 | 33,103,860 | $3,310 | $30,612,281 | $(27,550,996) | $3,064,595 |
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | (Deficit) | |
| December 31, 2023 | 26,526,405 | $3,310 | $17,778,498 | $(23,582,504) | $(5,801,354) |
| Stock-based compensation | - | - | 355,317 | - | 355,317 |
| Issuance of restricted stock for the forgiveness of accrued salaries and accrued bonuses | - | - | 10,000 | - | 10,000 |
| Issuance of stock options for the forgiveness of accrued salaries and accrued bonuses | - | - | 50,000 | - | 50,000 |
| Net loss | - | - | - | (634,100) | (634,100) |
| March 31, 2024 | 26,526,405 | $3,310 | $18,193,815 | $(24,216,604) | $(6,020,137) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.